Bacil Pharma Limited (BACPHAR.BO)
INR 60.12
(-1.99%)
INR 60.12
(-1.99%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 19.95 Thousand | 26.92 Thousand | 37.17 Thousand | 49.31 Thousand | 82.24 Thousand | 90.99 Thousand |
| Gross Profit | -19.95 Thousand | -26.92 Thousand | -37.17 Thousand | -49.31 Thousand | -82.24 Thousand | -90.99 Thousand |
| Operating Expenses | 1.87 Million | 1.76 Million | 1.58 Million | 1.36 Million | 1.88 Million | 2.63 Million |
| Selling, General and Administrative Expenses | 1.87 Million | 129.71 Thousand | 157.54 Thousand | 132.24 Thousand | 168.24 Thousand | 390.72 Thousand |
| Research and Development Expenses | - | - | - | 86.05 Thousand | 64.42 Thousand | - |
| Other Expenses | - | 1.14 Million | 576 Thousand | 739 Thousand | 12.00 | -350.54 Thousand |
| Cost and Expenses | 1.89 Million | 1.76 Million | 1.58 Million | 1.36 Million | 1.88 Million | 2.63 Million |
| Operating Income | -1.89 Million | -1.81 Million | -1.59 Million | -1.71 Million | -1.97 Million | -2.78 Million |
| Interest Expense | - | 14.17 Thousand | 8168.00 | 45.6 Thousand | 93.14 Thousand | 2324.00 |
| Income Tax Expense | 720.00 | -357.00 | -2180.00 | -4349.00 | -4039.00 | -11.13 Thousand |
| Earnings before Tax | -589.81 Thousand | -1.01 Million | -38.6 Million | -2.39 Million | -3.15 Million | -3.43 Million |
| Net Income | -590.53 Thousand | -1.01 Million | -38.59 Million | -2.39 Million | -3.15 Million | -3.42 Million |
| Earnings Per Share Basic | -0.10 | -0.17 | -6.55 | -0.41 | -0.54 | -0.58 |
| Earnings Per Share Diluted | -0.10 | -0.17 | -6.55 | -0.41 | -0.54 | -0.58 |
| Weighted Average Shares Outstanding | 5.89 Million | 5.89 Million | 5.89 Million | 5.89 Million | 5.89 Million | 5.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.89 Million | 5.89 Million | 5.89 Million | 5.89 Million | 5.89 Million | 5.9 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -569.32 Thousand | -991.16 Thousand | -38.56 Million | -2.34 Million | -3.07 Million | -3.34 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 4000.00 | 4000.00 | 5000.00 | 19.95 Thousand | 5000.00 | 5000.00 |
| Gross Profit | -4000.00 | -4000.00 | -5000.00 | -19.95 Thousand | -5000.00 | -5000.00 |
| Operating Expenses | 729 Thousand | 444 Thousand | 611 Thousand | 1.87 Million | 568 Thousand | 404 Thousand |
| Selling, General and Administrative Expenses | 725 Thousand | 444 Thousand | 611 Thousand | - | 568 Thousand | 399 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 729 Thousand | 108 Thousand | 212 Thousand | - | 329 Thousand | 288 Thousand |
| Cost and Expenses | 729 Thousand | 448 Thousand | 616 Thousand | 1.89 Million | 573 Thousand | 404 Thousand |
| Operating Income | -729 Thousand | -448 Thousand | -616 Thousand | -1.89 Million | -573 Thousand | -404 Thousand |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 34 Thousand | - | 2000.00 | 720.00 | 44.58 Thousand | -1000.00 |
| Earnings before Tax | 4.87 Million | -340 Thousand | -405 Thousand | -589.81 Thousand | -244 Thousand | -115 Thousand |
| Net Income | 4.84 Million | -340 Thousand | -405 Thousand | -590.53 Thousand | -244 Thousand | -115 Thousand |
| Earnings Per Share Basic | 0.82 | -0.06 | -0.07 | - | -0.04 | -0.02 |
| Earnings Per Share Diluted | 0.82 | -0.06 | -0.07 | - | -0.04 | -0.02 |
| Weighted Average Shares Outstanding | 5.9 Million | 5.89 Million | 5.89 Million | 5.89 Million | 5.89 Million | 5.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 5.9 Million | 5.89 Million | 5.89 Million | 5.89 Million | 5.89 Million | 5.89 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -725 Thousand | -444 Thousand | -611 Thousand | - | -568 Thousand | -399 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
GDI
BEKAY
ZYDUSLIFE
2420
UNIVCABLES
HGGCF